Sign In
Buy ILMN
$205.10
+0.0100 (+0.0049%)
At Close: Jul 31, 2026
Wild Ride For Illumina Stock Shows Promise, Challenge Of Multi-Cancer Blood Tests
08:30am, Friday, 13'th Nov 2020
Liquid biopsy technology offers promise of the medical Holy Grail, early detection of multiple cancers. Illumina, Exact Sciences deals heating up a game-changing field in cancer treatment.
Realize the Full Potential of the NextSeq 2000 with the Power of the P3 Reagent Kit
08:00pm, Thursday, 12'th Nov 2020
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ: ILMN) is further extending the reach of the NextSeq™ 2000 Sequencing System with the commercial availability of the P3 high-output flow cell. The
Why Illumina's Q3 Results Were Better Than They Might Seem
06:05am, Friday, 30'th Oct 2020
The genomic-sequencing leader is recovering more quickly from the COVID-19 pandemic than it anticipated.
Illumina Inc. (ILMN) CEO Francis deSouza on Q3 2020 Results - Earnings Call Transcript
10:48pm, Thursday, 29'th Oct 2020
Illumina Inc. (ILMN) CEO Francis deSouza on Q3 2020 Results - Earnings Call Transcript
Illumina: Q3 Earnings Insights
05:11pm, Thursday, 29'th Oct 2020
Shares of Illumina (NASDAQ:ILMN) were flat in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share were down 47.15% over the past year to $1.02, which beat
Better Buy: Illumina vs. Exelixis
06:57am, Wednesday, 28'th Oct 2020
These two stocks have very different methods of generating returns.
Was The Smart Money Right About Illumina, Inc. (ILMN)?
06:05pm, Tuesday, 27'th Oct 2020
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilitie
Why Illumina (ILMN) Stock is a Compelling Investment Case
12:00am, Monday, 26'th Oct 2020
Bonsai Partners recently released its Q3 2020 Investor Letter, a copy of which you can download here. The fund posted a return of 63.3% for the quarter (net of fees), outperforming their benchmark, th
Black Diamond Therapeutics: One To Watch In Precision Oncology Space (NASDAQ:BDTX)
05:00am, Friday, 23'rd Oct 2020
Black Diamond is an innovative cancer drug-developer using genetic sequencing to identify families of allosteric mutations, and developing drug molecules to inhibit their proliferation.
Laboratory Information Management System (LIMS) Market | Growing Demand For Bio-banking to Boost the Market Growth | Technavio
12:00am, Friday, 23'rd Oct 2020
The Global Laboratory Information Management System (LIMS) Market will grow by USD 705.85 mn during 2020-2024
Biodesix – A Lung Cancer Diagnostics Stock
05:11pm, Thursday, 22'nd Oct 2020
One can't help but wonder why the Americans are so worried about peanut allergies when 34 million of them use a product every day that slowly kills them. In the United States, cigarette smoking is l
Analysts Estimate Illumina (ILMN) to Report a Decline in Earnings: What to Look Out for
12:33pm, Thursday, 22'nd Oct 2020
Illumina (ILMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
